The Egyptian Drug Authority (EDA) recently held its 16th Board of Directors meeting, led by Ali El-Ghamrawi, Head of the Authority, at its headquarters in the New Administrative Capital. This gathering was part of ongoing efforts to advance Egypt’s pharmaceutical sector, enhance local manufacturing, and bolster the nation’s pharmaceutical security.
A key focus of the meeting was the EDA’s vision for modernizing the pharmaceutical system and aligning with international standards. The agenda covered updates on the Egyptian pharmaceutical market, progress on the digitization of internal processes, advancements on the Egyptian Pharmacopoeia, and recent international accreditations, all aimed at reinforcing Egypt’s position as a regional leader in the pharmaceutical industry.
One of the primary discussions centered on future plans to strengthen local pharmaceutical manufacturing and attract investment in the production of active pharmaceutical ingredients (APIs). The Authority aims to upgrade Egypt’s pharmaceutical facilities to meet domestic demand while expanding export opportunities, ultimately positioning Egypt as a pharmaceutical hub for Africa and the Middle East.
Further, the EDA emphasized its ongoing efforts to build human capacity through specialized training programs at its Professional Development Centre. These initiatives target pharmaceutical professionals across various sectors, focusing on technical and administrative skills while fostering international collaboration and knowledge exchange.